Biograph, Caristo Diagnostics Team Up for First-of-its-Kind U.S. Study to Advance AI-Powered Heart Disease Prevention

Sept. 30, 2025 — Biograph and Caristo Diagnostics have announced a partnership for Biograph to become the first…

Continue Reading
AMA Approves CPT Codes for Caristo’s AI-Powered Heart Disease Risk Stratification and Prevention Technology

AMA Approves CPT Codes for Caristo’s AI-Powered Heart Disease Risk Stratification and Prevention Technology

New CPT codes mark a major step toward making Caristo’s CaRi-Heart®—the first AI-powered tool to detect…

Continue Reading
Caristo Secures FDA Clearance, Ushering in a New Era of AI-Powered Heart Attack Prevention

Caristo Secures FDA Clearance, Ushering in a New Era of AI-Powered Heart Attack Prevention

FDA 510(k) clearance of Caristo’s CaRi-Plaque™ technology advances AI innovator’s U.S. commercialization, as it looks to roll…

Continue Reading